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Abstract
Background: Gene expression profiling has become a tool of choice to study pathological or developmental questions but in
most cases the material is scarce and requires sample amplification. Two main procedures have been used: in vitro transcription
(IVT) and polymerase chain reaction (PCR), the former known as linear and the latter as exponential. Previous reports identified
enzymatic pitfalls in PCR and IVT protocols; however the possible differences between the sequences affected by these
amplification defaults were only rarely explored.
Results: Screening a bovine cDNA array dedicated to embryonic stages with embryonic (n = 3) and somatic tissues (n = 2), we
proceeded to moderate amplifications starting from 1 μg of total RNA (global PCR or IVT one round). Whatever the tissue,
16% of the probes were involved in deviating gene expressions due to amplification defaults. These distortions were likely due
to the molecular features of the affected sequences (position within a gene, GC content, hairpin number) but also to the relative
abundance of these transcripts within the tissues. These deviating genes mainly encoded housekeeping genes from physiological
or cellular processes (70%) and constituted 2 subsets which did not overlap (molecular features, signal intensities, gene ID).
However, the differential expressions identified between embryonic stages were both reliable (minor intersect with biased
expressions) and relevant (biologically validated). In addition, the relative expression levels of those genes were biologically
similar between amplified and unamplified samples.
Conclusion: Conversely to the most recent reports which challenged the use of intense amplification procedures on minute
amounts of RNA, we chose moderate PCR and IVT amplifications for our gene profiling study. Conclusively, it appeared that
systematic biases arose even with moderate amplification procedures, independently of (i) the sample used: brain, ovary or
embryos, (ii) the enzymatic properties initially inferred (exponential or linear) and (iii) the preliminary optimization of the
protocols. Moreover the use of an in-house developed array, small-sized but well suited to the tissues we worked with, was of
real interest for the search of differential expressions.
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Background
Several years ago gene expression profiling has emerged as
a tool of choice to study developmental kinetics [1] and is
now widely used to study mammalian oocytes or embryos
(mouse: [2]; bovine: [3,4], human [5], porcine [6])
including questions on cell lineage differences [7]. How-
ever intermingled cells within complex tissues, biopsies,
early embryos or single cells give rise to ng or pg amounts
of RNA so that amplification has become a prerequisite,
coupled sometimes to laser capture micro-dissection (for
example [8]).
Two amplification methods have been reported in the
90ties [9,10], a linear procedure based on the use of In
Vitro Transcription (IVT) and an exponential procedure
based on the use of the Polymerase Chain Reaction
(PCR). These exponential and linear definitions have
been based on the dynamics of the corresponding enzy-
matic reactions with no implicit reference to their intrinsic
pitfalls. However, it has quickly become "obvious" that
the linear process was a high-fidelity process which guar-
anteed the conservation of the initial transcript abun-
dances [11]. It thus became the tool of choice for gene
profiling studies on cDNA and oligo-nucleotide arrays
[12]. In the meantime, global PCR amplification proce-
dures have been optimised and claimed better than IVT
for array screening when starting from the sub-pg quanti-
ties of RNA isolated from single cells [7,13]. As a conse-
quence, numerous reports have compared the
performance of PCR and IVT on decreasing amounts of
starting material. Some of these extended the comparison
to mRNA or total RNA as un-amplified standards
although these standards appeared debatable [14].
Since their first use, both linear and exponential amplifi-
cation processes became commercially available
(reviewed in [14,15]) and evolved into 8 to 10 different
protocols. The original IVT protocol [16] has been worked
out by Baugh et al. [17] to make it more specific, by Moll
et al. [18] to make it more efficient and by Schlingemann
et al. [19] to adapt it to oligo-arrays composed of sense
oriented oligonucleotides. Similarly, the original PCR
protocol has evolved into a new amplification process
known as the SMART protocol [20]. Several reports com-
pared SMART amplified targets to IVT [21] and/or global
PCR [22]. Improvements of the original Brady's protocol
have also been worked out and compared to total RNA
[7]. At last, alternatives to IVT or PCR have also been pro-
posed such as a PCR step followed by an IVT step, an IVT
step followed by a PCR step, the use of single-stranded
cDNA instead of double-stranded cDNA (ribo-SPIA pro-
tocol) or the use of subtraction prior to RNA amplification
(STAR protocol). These recent procedures have also been
compared to IVT or total RNA and sound promising
(reviewed in [14,15]). They fall beyond the scope of this
paper.
In all these studies fidelity, reproducibility and linearity of
RNA amplification has been a major concern and increas-
ingly refined statistics have been used accordingly (corre-
lation, fold change, T-test, ANOVA; [23]) to identify
amplification biases through deviating expression pat-
terns between amplified and un-amplified material. How-
ever, the possible differences between the sequences
affected by PCR and IVT amplification defaults were only
rarely explored. We thus aimed at studying the biases of
moderate amplification protocols as well as their major
characteristics, using an in-house developed protocol for
the global PCR amplification [24,25] and taking into
account in-house criteria linked to our biological pur-
poses. We thus decided to use a small set of in vivo elon-
gating embryos, recovered after uterus flushing, to screen
different arrays with the same embryonic material (this
study, [26,27]). Second, we chose a bovine array dedi-
cated to these bovine stages rather than a larger Affymetrix
array where sequences from this embryonic repertoire
were not present. Third, we preferred moderate amplifica-
tions to intense ones, as routinely practiced on oocytes
and earlier embryonic stages, since intense amplifications
cost more and have drawbacks too.
On this basis, we showed that deviating expressions
affected 16% of the array after PCR or IVT amplifications,
formed 2 gene subsets which did not overlap (molecular
features, signal intensities, gene ID) and corresponded to
housekeeping genes from physiological or cellular proc-
esses. Nevertheless, differential expressions were relevant
and displayed relative expression levels which were bio-
logically similar, though not identical, between amplified
and unamplified samples.
Results
Experimental design
Our purpose was to analyse moderate amplifications on
tissues of similar but also different molecular complexities
to analyse the relevance and biases in gene profiling stud-
ies following RNA amplification. To this aim, we selected
two protocols (IVT one round and global PCR) and five
tissues: three embryonic tissues of equivalent molecular
complexities as revealed by SAGE data on ovoid, tubular
and filamentous stages in pig [28] and two adult tissues of
different complexities (brain and ovary) as described by
human SAGE and EST data [29].
To focus the design on technological variability, we
reduced the biological variability as much as we could
(Fig. 1). For example, the tissues (embryos, brain and ova-
ries) were collected on a limited number of pregnant
cows. Total RNA from brain and ovary was extracted fromBMC Genomics 2008, 9:46 http://www.biomedcentral.com/1471-2164/9/46
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different pieces of tissue and pooled thereafter to get a sin-
gle RNA pool for each tissue. Similarly, RNA from individ-
ual embryos was extracted and pooled per stage since
biological pooling was acceptable there due to our meth-
odological focus [30]. Global PCR or IVT one round was
then applied to 1 μg of total RNA from each tissue. Con-
comitantly, poly A+ RNA from brain and ovary was puri-
fied from the corresponding pools of total RNA and used
in slot-blots to assess the biological quality of the ampli-
fied material. This has not been done on embryos due to
a limited amount of material. We chose slot-blots instead
of real-time PCR to assess the quality of the amplified
material since a validation of a global PCR by a PCR did
not seem reasonable to us due to similar enzymatic draw-
backs.
Amplified material from each tissue (brain, ovary, ovoid
embryos, tubular embryos and filamentous embryos) was
indirectly labelled using "random" hexamers. As advised
[31] replicates were emphasized and deliberately focused
on technical points. Three or two independent targets for
each tissue and each protocol (target replicates) were thus
generated and hybridised to 4 replicates of the same array
(array replicates), so that 48 measurements per probe
were generated for somatic (3 targets × 2 tissues × 2 proto-
cols × 4 arrays) and embryonic samples (2 targets × 3 tis-
sues × 2 protocols × 4 arrays). To find out gene expression
differences between protocols or embryonic stages, appro-
priate statistical analyses have been applied on each set of
data.
RNA amplifications: optimisation and quality
Since drawbacks were reported for both IVT and PCR
based protocols which could originate from a too long IVT
(degradation effect reported by Spiess [32]) or too many
cycles of PCR (saturation effect reported by Cha or Nagy
[33,34]), we first challenged our protocols on our tissues
to define optimal amplification conditions. The protocols
were tested using increasing in vitro transcription time or
PCR cycle number, with a special look at 5 transcripts: 3
endogenous and 1 exogenous transcripts in brain and
ovary, 1 endogenous transcript in developing embryos.
Transcripts encoding EF1α, L23a and Cytochrome oxidase
III were selected as somatic controls because of a differen-
tial expression between brain and ovary, an easy detection
on slot blots with poly A+ RNA and a different length: 1.7,
0.9 and 0.7 kb, respectively (preliminary data, not
shown). As a result, an in vitro transcription of 10 h and 2
rounds of 12 PCR cycles on 1/10 of the reverse transcrip-
tion looked optimal since (i) the size of the "spiking"
transcripts was conserved (ii) no shortage or degradation
of the amplified material was observed and (iii) the
amount of spiking transcripts had increased linearly with
the time of the IVT or the number of cycles in the PCR [see
Additional file 1].
Comparing the 3 amplified targets generated on the
somatic tissues, it appeared that the anti-sense RNA (or
aRNA) obtained after IVT corresponded to molecules of
0.1 to 4 kb with a mean size of 600 bp while the cDNA
fragments generated by global PCR were reduced in size:
0.1 to 1 kb, with a mean size of 150 bp [see Additional file
2A–B]. Interestingly cDNA populations were similar for
brain and ovary (panel B) whereas aRNA populations dis-
played slightly different patterns (panel A). However, the
3 aRNA targets generated from brain or ovary were similar
[see Additional file 2C]. These results underlined a good
reproducibility in the production of target replicates, a
slightly different distribution of RNA species between tis-
sues with IVT and a more homogeneous pattern between
tissues with PCR.
To further assess the quality of the amplified material gen-
erated on each tissue by IVT or PCR, we took advantage of
the endogenous and exogenous transcripts which were
used to calibrate the protocols and studied their expres-
sion in amplified versus un-amplified material (somatic
samples: Fig. 2A, embryonic samples, Fig. 2B). The L23a
mRNA, slightly more expressed in ovary than in brain
according to poly A+ RNA, kept the same profile after
amplification (IVT or PCR). Conversely, the stronger
expression of EF1α in the ovary was either increased (IVT)
Experimental design Figure 1
Experimental design. Description of the technical steps 
involved in the experiments designed to analyse the rele-
vance and biases occurring in our gene profiling studies fol-
lowing moderate RNA amplification: IVT one round or global 
PCR (details on the protocol in the Methods). In this design 
technical replicates included both target replicates (inde-
pendently amplified targets) and array replicates (identical 
copies of the array).
RNA Isolation
polyA+ 1μg total RNA
Slot blots (Fig. 2A)
PCR Amplification Linear Amplification
cDNA Synthesis cDNA Synthesis
T7 In Vitro Transcription
(1 round) 
PCR 1
(1/10 RT)
500ng 500ng
Random Radioactive Labelling
Hybridization on 4 array replicates
PCR 2
(1/4 PCR1)
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or attenuated (PCR) whereas the stronger expression in
brain of the Cytochrome Oxidase III mRNA was weak-
ened after IVT and abolished after PCR. Interestingly
enough the exogenous mRNA, which was equally added
in the RNA from brain and ovary (see Methods), appeared
more expressed in the ovary after IVT but not after PCR.
Using the Interferon-tau transcript as endogenous control
for bovine developing embryos (Fig. 2B) we showed that
the amount of this sequence increased from the ovoid to
the filamentous stage after amplification (IVT or PCR) as
it does in vivo (reviewed in [35]). On this very small set of
transcripts it was obvious that under and over representa-
tions occurred during amplification, but to which extent
and with which impact on gene expression differences?
Global features of somatic and embryonic hybridisations
As previously advised by N'Guyen [36], we first deter-
mined the amount of labelled target to be used for each
hybridisation so that no additional signal appeared but
the intensity of the positive signals increased when the
amount of target did (50, 125, 250 and 500 ng for aRNA
or cDNA labelled targets; data not shown). On this basis,
125 ng of each target has been hybridised to each array
with no particular focus on the relative amplification rates
and the subsequent equivalence between these targets.
Considering the somatic hybridisations, PCR amplified
targets gave a double amount of valid signals as compared
to IVT amplified ones (Fig. 3A), when valid meant
observed on 2 thirds of the arrays. In this case, common
signals represented 90% of the IVT signals but only 45%
of the PCR ones. This however was not true when valid
meant detected on all the arrays with intensities 2 times
over the background. Indeed, such a stringent calculation
gave similar numbers of signals with IVT or PCR amplifi-
cations: 112 versus 96 with brain and 167 versus 146 with
ovary, respectively. Conversely, embryonic targets (Fig.
3B) displayed similar numbers of signals at each stage but
2 to 3 times more signals than somatic ones, as expected
from an array enriched in embryonic probes. Moreover,
common signals between embryonic targets represented
70 to 80% of the signals generated by IVT and PCR ampli-
fications.
When analysed per protocol, the technical replicates (tar-
get replicates: 3 for the somatic tissues; 2 for the embry-
onic stages; array replicates: 4 per target) proved to be
nicely correlated as evidenced by the corresponding scat-
ter plots (Fig. 4A–B). Briefly, the coefficients of correlation
were between 0.85–0.97 for the hybridisations after PCR
or IVT amplification: 0.85 to 0.96 for the somatic signals
and 0.95 to 0.97 for the embryonic ones (Fig. 4D). How-
ever, the correlation between PCR and IVT amplified
products was much lower (0.39 to 0.67 for somatic
hybridisations; 0.58 to 0.67 for embryonic ones; Fig. 4C–
D). The scatter plots revealed additionally a large number
of signals with a very low coefficient of correlation which
corresponded to signals of high intensity with PCR ampli-
fications but low intensity with IVT and vice versa (Fig.
4C). These signals generated a crab-like figure of high
interest with respect to amplification distortions.
We thus confirmed a high correlation within methods, an
intermediate correlation between methods and evidenced
a divergence between methods for at least a subset of the
array. We thus aimed at its characterisation.
Amplification distortions in somatic and embryonic 
hybridisations
Gene expression differences between amplification meth-
ods (global PCR and IVT one round) were identified with
the TMEV 3.0 software. Analysing the whole array (1920
EST), 341 gene expression differences were identified
whatever the tissues. Interestingly most of them were
localised into the "crab claws" previously identified in the
scatter plots between PCR and IVT amplified samples (Fig.
5A). Before any other analysis this result suggested that
these differences were amplification discrepancies.
Repeating the analysis on the core array (987 EST, see
Methods), 154 gene expression differences appeared sig-
nificant between PCR and IVT amplified samples. These
Quality of the somatic and embryonic amplified products Figure 2
Quality of the somatic and embryonic amplified 
products. 125 ng of each amplified material (aRNA or 
cDNA) has been spotted onto a membrane and hybridised 
with DNA probes encoding exogenous (CG03) or endog-
enous controls (somatic: EF1α, L23a, cytochrome oxidase III; 
embryonic: IFN-tau). Each replicate (1 to 3) has been gener-
ated independently with each protocol (IVT or PCR) on each 
tissue (A: brain, ovary; B: ovoid, tubular and filamentous 
bovine embryos). PolyA+ RNA was used as standard for 
somatic tissues only (A).
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ones localised differently (Fig. 5B), showing that the crab
claws were mostly due to the mitochondrial sequences
(among which 12SrRNA) which were largely redundant
(33%) within the whole array. Though biologically not
challenging, this drawback (due to the fact that the embry-
onic library was neither normalised nor sequenced when
arrayed) highlighted a specific PCR bias towards 12SrRNA
sequences which could not be visualised on arrays con-
taining highly selected cDNAs. Reverse transcription
being mostly achieved on total RNA, this however was of
methodological interest since those sequences incorpo-
rate a part of the isotope during the labelling.
Applying a clustering analysis to the relevant differences
identified between amplified samples from embryonic
and somatic tissues (n = 154), 109 appeared at first glance
attributable to IVT and 45 to PCR (Fig. 6A). However, in
the absence of unamplified standards such as mRNA tar-
gets or total RNA targets, one cannot distinguish higher
IVT expressions due to IVT induced over-expressions or
Venn diagrams on somatic (A) and embryonic (B) hybridisations Figure 3
Venn diagrams on somatic (A) and embryonic (B) hybridisations. Only valid signals were displayed here after hybrid-
isation on the array. A signal was considered "valid" when the Imagene software did not flag it (flag = 0) and when the same sig-
nal was observed on 2 thirds of the arrays, namely: 8 out of 12 for the somatic ones and 5 out of 8 for the embryonic ones.
ABBMC Genomics 2008, 9:46 http://www.biomedcentral.com/1471-2164/9/46
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PCR induced under-expressions, and vice versa. We thus
named these groups of genes Panel 1 and Panel 2 instead
of IVT and PCR. Most of these deviating expressions cor-
responded to genes involved in similar processes: 75%
and 71% in physiological and cellular processes, respec-
tively (Fig. 6B). As expected from the clustering results, the
deviating gene differences from Panel 1 fell into the high-
est intensities of the IVT data and lowest intensities of the
PCR data whereas those from Panel 2 showed the oppo-
site distribution (Fig. 6C). Obviously, the density of these
deviating genes over unamplified data would have been
of high interest to sort out the part of IVT and/or PCR
defaults in these deviating expression differences. 64 and
32 genes referenced in the Unigene Bos taurus index were
respectively identified within Panel 1 and Panel 2 [see
Additional files 3 and 4]. In Panel 1, the endogenous con-
trols encoding RPL23a and EF1α were recognised thus
confirming that some of the deviating expressions we
observed on Fig. 6 were due to IVT induced over-expres-
sions (see Fig. 2). To further know whether molecular fea-
tures such as transcript size, GC content or presence of
hairpins could partly explain such deviations, we explored
these features on the amplification affected sequences
from both Panels.
We first found (Fig. 7A–E) that the sequences from Panel
2 (i) displayed a reduced size as compared to those from
Panel 1: 200 pb against 350 pb (ii) corresponded to sig-
nificantly smaller sized cDNAs: 850–950 pb against 900–
1800 pb (iii) were more frequently located in the 3' end
of the cDNAs: 25 to 50% of the Bt. length and (iv) dis-
played a lower GC content. Nevertheless, this last differ-
ence stopped being significant when the full length
cDNAs were compared (Fig. 7D–E) likely due to a "buff-
ering" effect of the coding regions where the GC contents
are often closer to 45%. Considering hairpins as potential
pausing sites, dA stretches as internal oligo-dT priming
sites and promoter-like sequences as alternative RNA
polymerase initiating sites, we then observed that
sequences from Panel 2 contained also more hairpins
Scatter plots between hybridisations with bovine adult brain (A-C) and correlations within the whole design (D) Figure 4
Scatter plots between hybridisations with bovine adult brain (A-C) and correlations within the whole design 
(D). Signal mean intensities were calculated for each amplified target on 4 arrays and plotted pair-wise per replicate. For exam-
ple, PCR-amplified: replicate 1 versus replicate 2 (A) and IVT-amplified: replicate 1 versus replicate 2 (B). Similar results were 
obtained for the 4 other pairs (1 versus 3 and 2 versus 3). Signal mean intensities per protocol were calculated on 12 arrays (4 
arrays per replicate × 3 replicates) and plotted pair-wise per protocol (C): PCR-amplified versus IVT-amplified. Similar results 
were obtained for the ovary and the embryos (ovoid, tubular and filamentous stages). Correlation factors between hybridisa-
tion profiles (D).
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(60% versus 37%) and A stretches (10% versus 5%) than
those from Panel 1. They displayed however similar con-
tents of promoter-like sequences (Table 1).
Conclusively, it appeared that systematic biases arose dur-
ing both amplification procedures independently of (i)
the sample used: brain, ovary or embryos, (ii) the enzy-
matic properties initially inferred (exponential or linear)
and (iii) the preliminary optimisation of the protocols.
These distortions affected 16% of the core array (154/
987) and involved different subsets of genes (Panels 1 and
2) which harboured different molecular properties.
Gene expression differences between embryonic stages
Knowing from above that systematic biases arose during
amplification (global PCR and IVT one round) and
affected 16% of the core array (987 EST), we wondered
whether gene expression differences identified between
embryonic stages with amplified samples could be both
reliable and relevant.
49 gene expression differences were identified between
stages (ovoid, tubular and filamentous) with PCR ampli-
fied samples and 28 with IVT amplified ones. Among
these, 14 were IVT specific, 35 PCR specific and 14 were
Evidence for gene expression differences between PCR and IVT amplified samples Figure 5
Evidence for gene expression differences between PCR and IVT amplified samples. Signal mean intensities per pro-
tocol were calculated on 24 arrays (4 arrays per target × 3 targets × 1 tissue = brain) and plotted pair-wise per protocol: PCR-
amplified versus IVT-amplified using either the whole set of data (A) or its biological core (B). Coloured, the signals identified 
as significant gene expression differences between protocols whatever the tissues (n = 154; red: global PCR; blue: IVT one 
round).
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commonly identified (Fig. 8A). The common ones (n = 14
EST) encoded 4 genes referenced in the Unigene Bos tau-
rus index and corresponded to transcripts identified in
another study using IVT amplified samples only [26]. We
showed therein that c12, c93, c88 and TKDP1 transcripts
were differentially expressed among these stages (c12,
c93: Northern blots; TKDP1 [37]). The IVT specific differ-
ences (n = 14) encoded 8 genes referenced in the Bos tau-
rus index, 4 of which were known as reliable differential
expressions: IFN-tau (our endogenous control for
Characterisation of PCR and IVT amplification biases Figure 6
Characterisation of PCR and IVT amplification biases. Unsupervised hierarchical clustering of the significant gene 
expression differences (n = 154) identified between PCR and IVT amplified samples whatever the tissues (A). Biological proc-
esses concerned by these gene expression distortions as defined by a search through Gene Ontologies (B). Representations of 
the deviating gene expressions on the core array: n = 987 EST as compared to the whole IVT and PCR datasets (C): the black 
lines correspond to the distribution of the intensities in each dataset; the red lines and the blue lines correspond respectively 
to densities of the deviating expressions from Panel 1 and 2.
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embryos, Fig. 2B), Cox2 [38], c12 and PAG11 [26]. Simi-
larly, the PCR specific differences (n = 35) encoded 15
genes referenced in the Bos taurus index, 5 of which were
also known as reliable differences: c12, c93, TKDP1,
PAG11 and IFN-tau. Surprisingly, they were not identified
as common differences between PCR and IVT amplified
samples. Looking in more details at the corresponding
EST it appeared clearly that, although located in the same
Bt., they did not overlap. Extending this analysis to the list
of specific differences (n = 49; 35 +14) we found that the
EST from the PCR group were frequently located at the
3'end of the referenced cDNAs (or Bt.), as compared to
those from the IVT group (Fig. 8B), and displayed reduced
sizes (Fig. 8C). Last but not least, a few differences identi-
fied between embryonic stages with PCR amplified sam-
ples (2 Bt./15) matched with those identified in Panel 2 (2
Bt./32) whereas no intercept was detected with Panel 1.
Since these differential patterns were detected with ampli-
fied embryonic targets, we compared their relative expres-
sion ratios between amplified and unamplified RNA
(Table 2). We thus quantified c12, c93 and PAG11 expres-
sion levels between stages as revealed by former Northern
blots [26] and performed Real-Time PCR on 2 new tran-
scripts: Cox2 (identified only by IVT targets) and IFN-tau
(identified by IVT and PCR targets through non overlap-
ping EST). From these results, one clearly sees that the dif-
ferential ratios between stages were biologically similar,
Molecular features of the gene subsets affected by amplification defaults Figure 7
Molecular features of the gene subsets affected by amplification defaults. The EST from Pane1 1 (n = 109) and Panel 
2 (n = 45) were compared to the EST of the core array (or 1 K array; n = 987) whenever interesting. The distributions of EST 
size, Bt. size and EST positions within the referenced transcripts from the Bos taurus Unigene index (or Bt.) were represented 
by box plots (A-C). Sizes were expressed in base pairs. Positions within the Bt. were expressed as % of the whole Bt. size, 
starting from the 5' end which is defined here as 0. The GC content in these subsets and in the corresponding Bt. was also rep-
resented by box plots (D-E). Boxes from the box-plots extended from the 25th percentile to the 75th percentile with a horizon-
tal bar representing the median. Statistical significance between median EST size, Bt. size, EST positions and GC contents has 
been estimated with T tests (null hypothesis: no differences). (*) means significant (P < 0.05) and (***) highly significant (P < 
0.01).
EST size Bt size EST position within Bt
EST GC content Bt GC content
* *** ***
***
1K array Panel 2 Panel 1 Panel 2 Panel 1 Panel 2 Panel 1
Panel 2 Panel 1 1K array Panel 2 Panel 1
A
D
B
a
s
e
 
p
a
r
i
s
B
a
s
e
 
p
a
r
i
s
P
o
u
r
c
e
n
t
a
g
e
5
’
p
o
s
i
t
i
o
n
 
 
 
 
 
3
’
P
o
u
r
c
e
n
t
a
g
e
BC
EBMC Genomics 2008, 9:46 http://www.biomedcentral.com/1471-2164/9/46
Page 10 of 15
(page number not for citation purposes)
though not identical. Indeed, the differential ratios for
Cox2 looked smaller at some stages with IVT targets
whereas the differential ratios of IFN-tau, c12 and PAG11
appeared smaller with PCR targets. Nevertheless, only one
inverted ratio appeared between IVT and PCR: the c12
ratio between tubular and filamentous stages.
As a final view, gene expression differences identified
between embryonic stages with amplified samples were
both reliable (tiny intersect with deviating expressions)
and relevant (biologically valid). In addition, the molecu-
lar features observed on the differential EST identified by
IVT or PCR amplifications suggest that global PCR
favoured the representation of short cDNA harbouring
rather low GC contents.
Discussion
This work illustrated the questions frequently asked since
2002 about RNA amplification and showed that even
with optimised and reproducible protocols deviating gene
expressions affected 16% of our array and appeared what-
ever the tissue. These biases, linked to the abundance or
the molecular features of the sequences affected by ampli-
fication defaults, corresponded mainly to housekeeping
genes from physiological and cellular processes. Differen-
tial expressions, however, were found reliable and rele-
vant with biologically similar expression ratios between
amplified and unamplified material.
Similar biases were reported in previous studies using also
moderate IVT and PCR amplifications. They evidenced
either contradictory expression ratios or missing spots
[39,40] but also a vast majority of expression patterns
which differed only in the magnitude of the differential
expression [41]. In our study, only one gene out of the five
tested showed an inversed ratio at one stage after PCR
amplification, whereas most of them showed ratios which
differed only in their magnitudes. All of them however
were relevant as confirmed by Northern blots or Real-
Time PCR. Interestingly, the deviating genes from our
study corresponded mainly to housekeeping genes
whereas those identified by van Haaften (genes lost dur-
ing IVT amplification) rather included transcription fac-
tors. As an alternative to minimise distortions, Real-Time
detection of amplified products has been proposed to pre-
vent over-amplification in PCR-based protocols [34] and
a similar approach has been used before and after IVT
amplifications to discriminate between well and badly
amplified samples [40]. This has also been used to follow
IVT amplifications on bovine oocytes and early embryos
(Robert & Sirard, personal communication).
The possible differences between the sequences affected
by amplification defaults were however rarely explored.
Van Haaften observed that the reporters that disappeared
after IVT amplification (20% of them) had a GC content
Differential expressions between embryonic stages Figure 8
Differential expressions between embryonic stages. 
Venn diagrams on gene expression differences identified 
between embryonic stages with PCR and IVT amplified sam-
ples (A). The distribution of the EST positions within the ref-
erenced transcripts from the Unigene Bos taurus index (or 
Bt.) and the distribution of the EST size were represented by 
box plots (B, C). Positions within the Bt. were expressed as 
% of the whole Bt. size, starting from the 5' end which is 
defined here as 0 (B). Sizes were expressed in base pairs (C). 
Boxes from the box-plots extended from the 25th percentile 
to the 75th percentile with a horizontal bar representing the 
median. Statistical significance between median EST size or 
EST positions has not been evaluated.
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Table 1: Additional features on the gene subsets affected by 
amplification defaults. Hairpins, A stretches and promoter like 
sequences have been investigated. The parameters were the 
following: hairpins (minimal length: 10 nucleotides, maximal 
length: 100, maximal gap: 50), A stretches (size: 18A, maximal 
gap: 3), promoter of the T7 RNA polymerase (forward sequence: 
CCCTATAGTGAGTCGTATTA and reverse sequence, 
maximal gap: 6). Results on Panel 1 and 2 are summarised here. 
Statistical significance between subsets or features has not been 
evaluated.
panel 1 panel 2
palindromes
≥1 24/30 (80%) 45/65 (75%)
≥ 2 18/30 (60%) 22/60 (37%)
>2 9/30 (30%) 10/60 (17%)
dA streches 3/30 (10%) 3/60 (5%)
promoter-like 8/30 (27%) 12/60 (20%)BMC Genomics 2008, 9:46 http://www.biomedcentral.com/1471-2164/9/46
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of about 54% and displayed more hairpins of longer sizes
than the other reporters (80%). A higher GC content has
also been observed in deviating genes after PCR amplifica-
tion with the SMART protocol [21]. The authors correlated
this feature to the temperature of the enzymatic reaction
(68 to 72°C for the Taq Polymerase) and to the GC con-
tent of their plant genome. This was surprising to us since
GC rich fragments are often difficult PCR templates,
requiring sometimes DMSO or betaine addition. In our
study, we could not assign the distortions from Panel 1
and Panel 2 to IVT or PCR defaults since, without a stand-
ard, it was impossible to distinguish IVT over-expression
from PCR under-expression and vice versa. It was clear
however that these 2 gene subsets did not overlap: differ-
ent molecular features, different signal intensities and dif-
ferent gene ID. EST from Panel 2 displayed reduced sizes,
were more frequently located in the 3'end of the cDNAs
and displayed a lower GC content than those from Panel
1. They also contained more hairpins (60% versus 37%)
and A stretches (10% versus 5%) than those from Panel 1
but displayed similar contents of promoter-like
sequences. Since EST corresponding to true differential
expressions identified by PCR targets were frequently
located at the 3'end of the referenced cDNAs and dis-
played reduced sizes (as compared to IVT specific ones),
one would suggest that deviating genes from Panel 2
could display a PCR signature.
Conclusion
From this work, it was not really possible to favour PCR
over IVT amplification or vice versa. Both generated distor-
tions and revealed true differential expressions between
embryonic stages (minor intersect between differential
patterns and biases), so that one would rather advise (i)
using only one protocol to keep amplification factors and
biases equal (ii) monitoring the amplification process as
offered now through Real-Time PCR and (iii) searching
for protocol specific expression differences or gene-proto-
col interactions before any differential analysis on a new
dataset or a new array. Obviously, the choice between
those protocols is also a question of total RNA input,
time, cost and available arrays since amplified targets
enriched in 3'end fragments will not hybridise to SSH
fragments or 5'positioned oligos. Last but not least, know-
ing that Taq Polymerases make more mistakes than RNA
polymerases do, IVT may be favoured over PCR to hybrid-
ise highly discriminating oligo-arrays or arrays from other
species.
Methods
Bovine tissues
Estrus synchronized heifers of the Charolais breed were
inseminated (day 0) and day 12 to day 17 blastocysts were
collected by non surgical flushing in warm PBS. Ovoid
blastocysts (1–12 mm) came from collects at 12 dpi (day
post insemination) whereas tubular and early filamen-
tous stages (50–60 mm and 140–160 mm) were obtained
at 14 to 15 and 16 to 17 dpi, respectively. Brain and ova-
ries were collected on Day-50 pregnant cows. To take
adult somatic tissues, animals were humanly put down in
the accredited experimental slaughterhouse of INRA
under the supervision of veterinary services.
RNA extraction
Total RNA from ovoid (n = 4), tubular (n = 4) and fila-
mentous (n = 4) embryos was extracted with RNA-Plus™
(QBioGene). RNA quality was first verified by intact ribos-
omal bands on a 1% agarose gel (28S and 18S) and A260/
280 absorbance ratios. Total RNA from brain and ovary
was isolated in the same way. RNA quality was also veri-
fied by intact ribosomal bands on a 1% agarose gel (28S
and 18S) and A260/280 absorbance ratios. A spiking
mRNA was then added to brain and ovary as 1% of the
estimated polyA+ amount to test whether highly
expressed genes can be biased through amplification. This
CG03 mRNA from A. thaliana was in vitro synthesized
(with a T7 Megascript kit, Ambion) from the c554 con-
taining plasmid, given to us by H. Hofte (LBC, INRA Ver-
Table 2: Comparison of the differential expression ratios observed between embryonic stages using amplified and unamplified 
material. The expression ratios observed with amplified targets (IVT and PCR) come from the array datasets presented in this study. 
Those originating from Real-Time PCR come from the gene specific validations (IFN-tau, Cox2) we performed on unamplified RNA 
from each stage. Those originating from Northern blots (c12, c93, PAG11) come from previous results on unamplified RNA from each 
stage [26].
Array Northern Real-time PCR
IVT amplified material PCR amplified material (mRNA/18S) (mRNA/Gapdh)
Gene ov/tub tub/fil ov/fil ov/tub tub/fil ov/fil ov/tub tub/fil ov/fil ov/tub tub/fil ov/fil
IFN-tau -3,21 -1,57 -6,94 -2,4 -2,31 -5,55 -5,48 -1,57 -8,63
Cox2 -1,72 -1,26 -2,17 -1,22 -1,73 -2,10 -4,32 -1,74 -7,53
c12 4,93 3,86 8,51 1,87 -1,26 1,48 3,24 2,63 4,02
c93 -1,2 -1,83 -2,19 -1,66 -1,62 -2,67 -1,52 -2,87 -4,37
PAG11 -1,52 -2,87 -4,37 -1,49 -1,06 -1,58 -2,98 -1,3 -3,87BMC Genomics 2008, 9:46 http://www.biomedcentral.com/1471-2164/9/46
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sailles, France). Brain and ovary polyA+ RNA were further
extracted using a Dynabeads mRNA purification kit
(Dynal).
RNA amplification
Amplified RNA from each sample was synthesized with
the MessageAmp™ aRNA Kit (Ambion) according to the
manufacturer instructions. Briefly, 1 μg of total RNA was
incubated with 500 ng of an anchored T7-(dT) primer in
12 μl (water) at 70°C for 10 min. The 1rst cDNA strand
was synthesized by the addition of 2 μl first-strand buffer,
1 μl RNAse inhibitor, 4 μl dNTP mix and 1 μl reverse tran-
scriptase mix and incubation at 42°C for 2 h. Second-
strand synthesis was performed by the addition of 63 μl
DEPC-treated water, 10 μl second-strand buffer, 4 μl
dNTP mix, 2 μl DNA polymerase, 1 μl RNAse H- and incu-
bation at 16°C for 2 h. DNA was extracted with phe-
nol:chloroform:isoamyl alcohol and precipitated in
ethanol with 20 μg glycogen (Ambion). In vitro transcrip-
tion was carried out at 37°C for 10 h in a 20 μl reaction
volume. 1 μl DNAse was added and incubated at 37°C for
30 min. RNA was purified on Mini Quick Spin RNA col-
umns (Roche Diagnostic) and its quality verified on RNA
6000 lab-chips (BioAnalyser 2100; Agilent Technologies).
RNA target labelling
aRNA was retro-transcribed and directly labelled with [α-
33P]dATP as described for polyA+RNA [42]. 500 ng of
aRNA was mixed with 500 ng of random hexamers in a
volume of 25 μl. The mixture was incubated at 70°C for
10 min and chilled on ice. cDNA was synthesised by the
addition of 5 μl 10× PCR buffer, 5 μl 25 mM MgCl2, 5 μl
0,1 mM DTT, 2,5 μl 10 mM mix dGTP, dCTP and dTTP,
2,5 μl water, 50 μCi [α-33P]dATP and 200 U Superscript II
(Invitrogen) at 42°C for 50 min. The RNA template was
removed by the addition of 1 μl RNAse H- and incubation
at 37°C for 20 min.
Global RT-PCR amplification
Amplified cDNA was prepared as described [24] with few
modifications. Briefly, 1 μg total RNA was incubated with
1 μl 10 μM oligo(dT), 1 μl 10 mM dNTPs, 1 μl 10% NP40,
1 μl 20 mM DTT, 2 μl first-strand buffer 5×, 1 μl RNAse
inhibitor (Ambion) at 65°C for 2 min, at room tempera-
ture for 3 min and cooled on ice. cDNA was synthesised
by the addition of 200 U Superscript II (Invitrogen) and 2
U AMV (Gibco BRL) and incubation at 42°C for 30 min.
First-strand cDNA were poly(dG)-tailed by incubation
with 1 μl 20 mM dGTP, 4 μl TdT buffer 5×, 2,5 μl water,
2,5 μl TdT enzyme (Promega) at 37°C for 1 h. The first
PCR was performed in a volume of 50 μl using 1/10 of the
RT and the second PCR was performed on 1/4 of the first
PCR. Samples were incubated at 94°C for 10 min before
the two rounds of PCR cycles (12 cycles each; 94°C for 2
min, 63°C for 50 sec and 72°C for 6 min). PCR products
were then purified using Qiaquick PCR purification (Qia-
gen) and their quality verified on DNA 7500 lab-chips
(BioAnalyser 2100; Agilent Technologies).
cDNA target labelling
PCR-amplified cDNA was labelled with [α-33P]dATP
using random hexamers and Klenow included in Atlas
SMART Probe Amplification kit (Clontech). 500 ng of
amplified cDNA was mixed with 500 ng random hexam-
ers in a volume of 34 μl. The mixture was incubated at
98°C for 8 min and at 50°C for 3 min. After addition of 5
μl 10× buffer, 5 μl dNTPs for ATP label, 5 μl [α-33P]dATP
and 1 μl Klenow, the reaction mixture was incubated at
50°C for 30 min and stopped with 2 μl 0,5 M EDTA.
Labelled targets were then purified on Sephadex columns
(G-50).
Quantitative Real time PCR
Real-time PCR was carried out in a final volume of 30 μl
with 1 μl of diluted reverse transcriptions (1/100; 1/1000)
in a 1× SYBR green Master Mix (Applied Biosystems) with
0.3 μM of gene-specific primers. Reactions were run on
ABI Prism 7000 HT (Applied Biosystems). The presence of
a specific and unique PCR product was checked by ABI
Prism melting curves. The relative quantification of the
initial amount of target was extrapolated from the appro-
priate standard curve, which was generated simultane-
ously while using serial dilutions of the corresponding
PCR product. IFN-tau and Gapdh primers were as pub-
lished [43,44] but Cox2 primers were a kind gift from G.
Charpigny. Their sequences (unpublished so far) will be
available upon request gilles.charpigny@jouy.inra.fr.
Slot-Blot
125 ng of polyA+RNA, aRNA or cDNA were spotted and
cross-linked to HybondN+ membranes (Amersham) at
80°C for 2 h. DNA probes encoding IFN-tau, CG03, EF1α,
RPL23a or Cytochrome oxidase III were [α-32P]dCTP-
labelled using the Ready-Prime kit (Amersham). Apart
from CG03, those DNA probes originate from the array.
Hybridisations were conducted at 65°C for 16 h and
washes performed once in 2 × SSC, 0,1% SDS at 65°C for
30 min and twice in 0,1 × SSC, 0,1% SDS at 65°C for 10
min. Slot blots were then exposed to phosphor-imaging
for 24 hours and signal intensities quantified with the
ImageQuant 3.3 software (Molecular Dynamics).
Array description
The bovine embryonic array used here originates from a
bovine cDNA library established at the ovoid stage, start-
ing from 1.6 μg of RNA and using the Cap Finder cDNA
kit from Clontech as described in Degrelle et al. [26].
Briefly, cDNA inserts from the arrayed library were ampli-
fied by PCR using the flanking primers from the Cap
Finder kit and selected for spotting after a short run on aBMC Genomics 2008, 9:46 http://www.biomedcentral.com/1471-2164/9/46
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2.5% agarose gel. 1855 probes were then spotted and
fixed (UV light, 1 min, 1200 J, twice) onto nylon N+
membranes (8 cm × 12 cm, Amersham Biosciences) with
a 5 × 5 pattern (BioRobotics). This was achieved with the
kind help of C. Matingou and G. Piétu at the Genexpress
Laboratory headed by C. Auffray (CNRS FRE 2571, Ville-
juif, France). The library has been called "bcai" and
indexed in TGI and NCBI database as "#FJB" and
"15979", respectively [45,46] and the array published as
"INRA-BDR Bovine D14 Embryo 1K" (GPL6284) in NCBI
Gene Expression Omnibus database [47]. Bacterial clones
are available upon request at the CRB GADIE (INRA Jouy
en Josas, France [48])
Array hybridization, image acquisition and quantification
Each target was hybridized to 4 array replicates using
ExpressHyb™ Hybridization Solution (Clontech) at 68°C
overnight. Arrays were washed four times in 2 × SSC, 1%
SDS and once in 0.1 × SSC, 0.5% SDS at 68°C for 30 min
each. They were then exposed to phosphor-screens for 7
days. The hybridization signals were quantified with the
Imagene 3.1 software from BioDiscovery (Proteigene) on
the PICT plateform (INRA Jouy en Josas, France). These
raw datasets are accessible in NCBI Gene Expression
Omnibus database (experimental series "GSE9929" [47]).
Internal controls within the array corresponded to 65
probes and either positive or negative controls were as
expected in all the hybridizations. A signal was considered
"valid" when the Imagene software did not flag it (flag =
0) and when the same signal was observed on 2 thirds of
the arrays, namely: 8 out of 12 for the somatic targets and
5 out of 8 for the embryonic ones.
Gene expression analyses
All the plots (scatter plots, histograms) were performed
on R environment [49].
Gene expression differences between protocols
These analyses were performed either on the whole array
(1855 inserts plus 65 controls = 1920 probes) or on the
biological core of the array also called 1 K array (1097
informative sequences submitted to the EBI – 110 mito-
chondrial sequences = 987 probes). With 2 protocols, 5
tissues, 2 to 3 target replicates per protocol and 4 array
replicates per target (as indicated in the experimental
design, Fig. 1), these analyses involved 184 320
(1920*2*2*3*4+1920*2*3*2*4) and 94 752
(987*2*2*3*4+987*2*3*2*4) pieces of data, respec-
tively. Statistical and clustering analyses were performed
using TIGR MeV 3.0 (MultiExperiment Viewer software
[50]). Before calculations, the data were log2 transformed
and standardised within each protocol. Differences
between PCR and IVT methods were assessed by a Stu-
dent's t-test assuming an unequal variance (Welch
approximation). The adjusted Bonferroni correction was
considered at P < 0.05. An unsupervised hierarchical clus-
tering, based on Euclidean distance and complete linkage,
was performed on the significant gene expression differ-
ences between the 2 methods.
Gene expression differences between embryonic stages
These analyses were performed on the biological core of
the array (987 probes). With 2 protocols, 3 embryonic
stages, 2 target replicates per protocol and 4 array repli-
cates per target (as indicated in the design), these analyses
involved 47 376 (987*3*2*2*4) pieces of data. To iden-
tify gene expression differences between stages, we used a
set of SAS macros called AnovArray and performed an
analysis of variance considering a homogeneous variance
for all the genes (HOM option) and a multiple testing
(False Discovery Rate) at the threshold 5% (details in
[26,51]). AnovArray has been originally conceived to ana-
lyse these datasets.
Bioinformatics
Biological processes were analysed through Gene Ontol-
ogy annotations [52] considering the Indentation 1. EST
size, GC content, EST position according to the referenced
mRNA of the Bos taurus gene index [45] were performed
using Perl scripts and box plot function from the R envi-
ronment [49]. Presence of hairpins, dA stretches and
sequences similar to RNA polymerase promoters was eval-
uated using the palindrome and fuzznuc programs of the
Emboss package [53].
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Additional file 1
Optimisation of each amplification procedure. Southern (A) and 
Northern (B) blots performed on cDNA (A) and aRNA (B) after increas-
ing PCR cycle numbers or increasing in vitro transcription times were 
hybridised with a 32 P-labelled DNA probe encoding the exogenous CG03 
transcript. A band of the expected size (1 kb) was observed on southern 
blots after 9, 12 and 15 cycles for the 1rst and 2nd rounds of PCR amplifi-
cations (A). The negative controls including RT- and mock did not give 
any signal. A band of the expected size was also observed on Northern blots 
after 8, 10 or 12 h of in vitro transcription (B). Its intensity increased 
with the increasing transcription time. Only brain data are illustrated 
here, but similar results were obtained with ovary and embryos.
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Additional file 2
Characteristics of the amplified targets from brain and ovary. aRNA 
and cDNA targets were analysed on RNA 6000 lab-chips and DNA 7500 
lab-chips, respectively (BioAnalyser 2100; Agilent Technologies). These 
populations of amplified molecules displayed slightly different profiles of 
size distribution depending on the protocol (A, B) or the tissue (C). Each 
target replicate (1 to 3) has been amplified independently from the same 
pool of total RNA. The molecular ladders are represented in nucleotides 
(nt) on the x axis.
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Additional file 3
List of the 109 EST from Panel 1. Name of the EST from the 1 K array 
(or core array), GenBank accession numbers (CR), identifiers in TIGR 
gene index (TC) and Unigene index (Bt.) as well as short names (Gene 
ID) are provided here.
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List of the 45 EST from Panel 2. Name of the EST from the 1 K array 
(or core array), GenBank accession numbers (CR), identifiers in the 
TIGR gene index (TC) and the Unigene index (Bt.) as well as short 
names (Gene ID) are provided here.
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